we are

Cardiovascular Systems, Inc.

Leading The Way In The Fight Against Arterial Calcium

Leading the way by developing and commercializing innovative solutions for treating peripheral artery disease (PAD) and coronary artery disease (CAD).  Our primary focus is helping physicians fight calcium, given the complications it presents for the millions who suffer from PAD and CAD.






News from CSI

At CSI, we like to keep you informed of the latest information and news from our company. Find recent press releases, clinical study updates, product news, patient stories — and more — all supporting advances in our technology and company.

 



Patient Stories

Read about patients who have gotten back to what matters by having an orbital atherectomy procedure.


Improving
Patient
Access

By raising awareness of coronary artery disease (CAD) and peripheral artery disease (PAD) and encouraging screening, CSI is committed to help improve patient outcomes.

Addressing
Racial
Disparities

Research has shown minority populations are at greater risk of amputation with advanced PAD. CSI is working to reduce the gap through education campaigns and patient advocacy.

Delivering
Medical & Economic
Evidence

Addressing calcium in arterial disease has implications for all revascularization procedures. CSI is committed to providing value-based analysis through cost-effective, long-term outcomes.

Collaborating With
Healthcare
Providers

Across the globe, CSI is committed to collaborating with physicians and their teams, whether in a hospital or office-based lab, to help improve patient outcomes and manage costs.


400000+
Patients Served
2000+
Healthcare Facilities
650+
CSI Team Members


Contact us for more info


Contact